Agreement of Mammographic Measures of Volumetric Breast Density to MRI

被引:31
作者
Wang, Jeff [1 ]
Azziz, Ania [1 ]
Fan, Bo [1 ]
Malkov, Serghei [1 ]
Klifa, Catherine [2 ]
Newitt, David [1 ]
Yitta, Silaja [1 ]
Hylton, Nola [1 ]
Kerlikowske, Karla [3 ,4 ]
Shepherd, John A. [1 ]
机构
[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA
[2] Synarc Inc, Newark, CA USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Epidemiol Biostat, San Francisco, CA 94143 USA
来源
PLOS ONE | 2013年 / 8卷 / 12期
关键词
CANCER RISK; SCREENING MAMMOGRAPHY; TISSUE COMPOSITION; BODY-COMPOSITION; TAMOXIFEN; WOMEN; MODEL; REDUCTION; PATTERNS; INDEX;
D O I
10.1371/journal.pone.0081653
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Clinical scores of mammographic breast density are highly subjective. Automated technologies for mammography exist to quantify breast density objectively, but the technique that most accurately measures the quantity of breast fibroglandular tissue is not known. Purpose: To compare the agreement of three automated mammographic techniques for measuring volumetric breast density with a quantitative volumetric MRI-based technique in a screening population. Materials and Methods: Women were selected from the UCSF Medical Center screening population that had received both a screening MRI and digital mammogram within one year of each other, had Breast Imaging Reporting and Data System (BI-RADS) assessments of normal or benign finding, and no history of breast cancer or surgery. Agreement was assessed of three mammographic techniques (Single-energy X-ray Absorptiometry [SXA], Quantra, and Volpara) with MRI for percent fibroglandular tissue volume, absolute fibroglandular tissue volume, and total breast volume. Results: Among 99 women, the automated mammographic density techniques were correlated with MRI measures with R-2 values ranging from 0.40 (log fibroglandular volume) to 0.91 (total breast volume). Substantial agreement measured by kappa statistic was found between all percent fibroglandular tissue measures (0.72 to 0.63), but only moderate agreement for log fibroglandular volumes. The kappa statistics for all percent density measures were highest in the comparisons of the SXA and MRI results. The largest error source between MRI and the mammography techniques was found to be differences in measures of total breast volume. Conclusion: Automated volumetric fibroglandular tissue measures from screening digital mammograms were in substantial agreement with MRI and if associated with breast cancer could be used in clinical practice to enhance risk assessment and prevention.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] The Effect of Change in Body Mass Index on Volumetric Measures of Mammographic Density
    Hart, Vicki
    Reeves, Katherine W.
    Sturgeon, Susan R.
    Reich, Nicholas G.
    Sievert, Lynnette Leidy
    Kerlikowske, Karla
    Ma, Lin
    Shepherd, John
    Tice, Jeffrey A.
    Mahmoudzadeh, Amir Pasha
    Malkov, Serghei
    Sprague, Brian L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (11) : 1724 - 1730
  • [2] Using Volumetric Breast Density to Quantify the Potential Masking Risk of Mammographic Density
    Destounis, Stamatia
    Johnston, Lisa
    Highnam, Ralph
    Arieno, Andrea
    Morgan, Renee
    Chan, Ariane
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 208 (01) : 222 - 227
  • [3] Mammographic density, MRI background parenchymal enhancement and breast cancer risk
    Pike, M. C.
    Pearce, C. L.
    ANNALS OF ONCOLOGY, 2013, 24 : 37 - 41
  • [4] Mammographic Density Estimation with Automated Volumetric Breast Density Measurement
    Ko, Su Yeon
    Kim, Eun-Kyung
    Kim, Min Jung
    Moon, Hee Jung
    KOREAN JOURNAL OF RADIOLOGY, 2014, 15 (03) : 313 - 321
  • [5] Does MRI Breast "Density" (Degree of Background Enhancement) Correlate With Mammographic Breast Density?
    Hansen, Nienke L.
    Kuhl, Christiane K.
    Barabasch, Alexandra
    Strobel, Kevin
    Schrading, Simone
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2014, 40 (02) : 483 - 489
  • [6] Mammographic Breast Density Response to Aromatase Inhibition
    Vachon, Celine M.
    Suman, Vera J.
    Brandt, Kathleen R.
    Kosel, Matthew L.
    Buzdar, Aman U.
    Olson, Janet E.
    Wu, Fang-Fang
    Flickinger, Lynn M.
    Ursin, Giske
    Elliott, Catherine R.
    Shepherd, Lois
    Weinshilboum, Richard M.
    Goss, Paul E.
    Ingle, James N.
    CLINICAL CANCER RESEARCH, 2013, 19 (08) : 2144 - 2153
  • [7] Mammographic breast density and breast cancer risk: Evaluation using volumetric breast density software
    Koshi, Suzanne
    Singla, Veenu
    Singh, Tulika
    Prabhakar, Nidhi
    Bal, Amanjit
    Singh, Gurpreet
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (06) : 1258 - 1264
  • [8] Mammographic breast density and hormonal therapy during postmenopause
    Sobstyl, Malgorzata
    Tkaczuk-Wlach, Joanna
    Jakiel, Grzegorz
    PRZEGLAD MENOPAUZALNY, 2011, 10 (05): : 419 - 423
  • [9] Mammographic Variation Measures, Breast Density, and Breast Cancer Risk
    Heine, John
    Fowler, Erin
    Scott, Christopher G.
    Jensen, Matthew R.
    Shepherd, John
    Hruska, Carrie B.
    Winham, Stacey J.
    Brandt, Kathleen R.
    Wu, Fang F.
    Norman, Aaron D.
    Pankratz, Vernon S.
    Miglioretti, Diana L.
    Kerlikowske, Karla
    Vachon, Celine M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 217 (02) : 326 - 334
  • [10] Longitudinal Study of Mammographic Density Measures That Predict Breast Cancer Risk
    Krishnan, Kavitha
    Baglietto, Laura
    Stone, Jennifer
    Simpson, Julie A.
    Severi, Gianluca
    Evans, Christopher F.
    MacInnis, Robert J.
    Giles, Graham G.
    Apicella, Carmel
    Hopper, John L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (04) : 651 - 660